aXichem updates the status for its EU application for Feed Additive approval
aXichem AB (publ), that develops and markets natural analogue industrial chemicals, announces that the company has taken another step in the process for Feed Additive approval in EU for its product phenylcapsaicin as feed ingredient, under the brand aXiphen®. The answers to the questions that aXichem received at the end of December 2022, from the European Food Safety Authority (EFSA), were submitted in March. The submission is now registered and the so-called "clock stop", meaning the break in the allotted time of a total of six months that is set by EFSA to process this type of application, is lifted. The new legal deadline for EFSA's review process is now set to 17 June 2023.
“I’m pleased that we have left the “clock stop” phase and are moving forward with the process. I’m convinced that the thorough work we have put in when preparing the application, including environmental tests and studies of efficacy and tolerability, will serve us well," says Torsten Helsing, CEO of aXichem.
About phenylcapsaicin and aXiphen
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem’s proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Studies have proven the effectiveness of aXiphen® as an ingredient in poultry feed.
A study on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The study comprised 18 broiler farms with 57 broiler chicken houses and 1 659 540 broiler chickens. The study concluded that under the conditions of the study, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced both the number of farms and the number of houses with salmonella-positive floor boot swabs. The European model for production efficiency, EPEF, showed that breeding efficiency increased by 14% compared to traditional feeding.
The information was submitted, through the care of the contact person below, for publication on 3 April 2023, at 11:30 AM CET.
Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se
aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, nutraceuticals and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Västra Hamnen Corporate Finance, www.vhcorp.se. Read more about aXichem at www.axichem.se